SLC2A1 and leukemia: Rodriguez-Zabala et al. [48] demonstrate that GLUT1 knockout decreases leukemia cell growth and induces apoptosis in vivo, and that combined BAY-876 and IACS treatment increases survival of tumorigenic mice, as well as viability of AML patient samples [48].